NASDAQ · CNSY
Cerenome, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for CNSY has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.98 | $-0.98 | $-0.98 | 1 |
| Dec 2026 | $-0.91 | $-0.91 | $-0.91 | 1 |
| Mar 2027 | $-0.78 | $-0.78 | $-0.78 | 1 |
| Jun 2027 | $-0.78 | $-0.78 | $-0.78 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews- Zacks · Oct 22, 6:53 AM EDTNew Strong Sell Stocks for October 22ndCANG, CDZI and CNSY have been added to the Zacks Rank #5 (Strong Sell) List on October 22, 2026.
- Zacks · Oct 15, 3:47 AM EDTNew Strong Sell Stocks for October 15thCDZI, CNSY and CNTX have been added to the Zacks Rank #5 (Strong Sell) List on October 15, 2026.
- RTTNews · Sep 30, 10:33 AM EDTCerenome Provides Q3 Update On CNSide Diagnostics; Stock Up(RTTNews) – Cerenome, Inc. (CNSY) provided a third-quarter 2026 business update for its wholly owned subsidiary, CNSide Diagnostics, LLC, covering gross payer billings, medicare coverage efforts for its Tumour Cell Enumeration (TCE) test, and expansion of the CNSide testing menu.
- RTTNews · Sep 25, 2:41 PM EDT5 Biotech Stocks Making Headlines – ADRX, CNSY, JAGX, AGL, ONCO(RTTNews) – The following biotech and healthcare-related stocks were in focus on September 25, 2026, following developments including an initial public offering, diagnostic reimbursement expansion, regulatory fee waivers, value-based care expansion and portfolio investment change
- RTTNews · Sep 22, 11:18 AM EDTCerenome Expands CNSide Coverage Through Blue Cross Blue Shield Michigan Deal; Stock Up(RTTNews) – CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (CNSY), a CNS oncology company, announced that it has signed an in-network provider agreement with Blue Cross Blue Shield of Michigan effective September 1, 2026, to provide the CNSide Cerebrospinal
- RTTNews · Sep 10, 10:29 AM EDTCerenome Secures Up To $20 Mln Financing Facility From 3i;Extends Cash Runway Into 2028(RTTNews) – Cerenome (CNSY), a clinical-stage oncology company focused on central nervous system cancers, announced that it has entered into a financing agreement with 3i, LP for a senior secured facility of up to $20 million, with royalty-based repayments intended to support the
- Zacks · Aug 14, 5:30 PM EDTCerenome (CNSY) Reports Q2 Loss, Misses Revenue EstimatesCerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 3, 6:49 AM EDTPlus Therapeutics Rebranded As Cerenome With Focus Shift To CNS Oncology; 'CNSY' New Trading Symbol(RTTNews) – Plus Therapeutics Inc. (PSTV), a precision diagnostics company, announced on Friday a corporate rebranding as Cerenome Inc., effective from August 3, 2026. The company will begin trading on the Nasdaq Capital Market under the ticker symbol 'CNSY' from this date onwa
- RTTNews · Jul 20, 9:46 AM EDTA New CNS Cancer Treatment Playbook In The Making?(RTTNews) – Beginning in August 2026, this healthcare company focused on central nervous system (CNS) cancers will adopt a new name, following months of planning that reflect its evolution into an integrated CNS oncology platform.
- RTTNews · Jun 26, 7:37 AM EDTPlus Subsidiary CNSide Signs Agreement With Elevance For CNSide Assay Test For CNS Metastasis(RTTNews) – Plus Therapeutics Inc. (PSTV), a clinical-stage pharmaceutical company, on Thursday announced that its wholly owned subsidiary CNSide Diagnostics LLC has signed a national agreement with Elevance Health Inc. (ELV), a health benefits company, for the CNSide cerebrospin
- Zacks · May 15, 5:20 PM EDTPlus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue EstimatesPlus (PSTV) delivered earnings and revenue surprises of -11.11% and +8.21%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 11, 6:05 PM EDTCatalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue EstimatesCatalyst (CPRX) delivered earnings and revenue surprises of +23.44% and +1.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Cerenome, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.